How to Get Alprostadil (Caverject/MUSE) in South Dakota

What Is Alprostadil and Why Is It Prescribed?

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, dilates cavernosal arteries, and produces an erection sufficient for intercourse in men with organic, psychogenic, or mixed erectile dysfunction (ED). The FDA approved intracavernosal alprostadil (Caverject) for ED in 1995 and the urethral suppository form (MUSE) in 1996. 1

The landmark Linet et al. trial published in the New England Journal of Medicine (N=683 men with chronic ED) showed that intracavernosal alprostadil produced erections sufficient for intercourse in 94% of in-office test-dose administrations, compared with 11% in the placebo group (P<0.001). 2 At-home use over 6 months produced satisfactory intercourse in 87% of injection attempts among men who completed the study. 2

Alprostadil is the preferred second-line agent when PDE5 inhibitors (sildenafil, tadalafil, vardenafil) fail or are contraindicated, a recommendation endorsed by the American Urological Association's 2018 ED guideline. 3 Contraindications include penile anatomical deformity, sickle cell anemia, leukemia, thrombocythemia, polycythemia, and hypersensitivity to alprostadil. 1

Is Alprostadil Legal to Prescribe via Telehealth in South Dakota?

Yes. South Dakota permits synchronous telehealth visits for prescription purposes, and alprostadil is not a controlled substance under either federal or South Dakota law. South Dakota Codified Laws Chapter 36-4 governs medical practice and explicitly includes telehealth encounters as valid encounters for establishing a prescriber-patient relationship, provided the clinician holds an active South Dakota license or a multi-state compact privilege. 4

South Dakota joined the Interstate Medical Licensure Compact (IMLC), meaning out-of-state physicians with compact privileges may prescribe to South Dakota patients without a separate full license application. 5 Nurse practitioners and physician assistants in South Dakota have independent prescribing authority for non-controlled medications under South Dakota Codified Laws Chapter 36-9A and 36-4A respectively, so patients are not limited to MD prescribers. 4

Because alprostadil is prescription-only, a provider must evaluate the patient, document the indication, and issue a valid prescription before any pharmacy dispenses the drug. A brief asynchronous questionnaire alone does not meet this standard under South Dakota telehealth law. 4

How to Get an Alprostadil Prescription in South Dakota: Step by Step

Getting started is straightforward. The process from initial inquiry to medication in hand typically spans 3 to 7 days for most South Dakota patients.

Step 1: Choose a provider. Select either a South Dakota-licensed urologist, primary care physician, nurse practitioner, or physician assistant, or enroll in a telehealth platform whose providers hold South Dakota prescribing authority. Platforms such as HealthRX connect patients to licensed clinicians who are authorized to prescribe in South Dakota.

Step 2: Complete a health history. The provider needs your cardiovascular history, a list of current medications (particularly anticoagulants and antihypertensives), any prior ED treatments, and your International Index of Erectile Function (IIEF) score or equivalent symptom documentation. Baseline testosterone screening is commonly ordered because hypogonadism can coexist with vascular ED and alter treatment response. 6

Step 3: Lab work. Most prescribers order a morning total testosterone, complete blood count, comprehensive metabolic panel, lipid panel, fasting glucose, and HbA1c. This panel helps rule out reversible causes of ED and satisfies prior authorization documentation requirements for commercial insurers. 6 A CBC is particularly relevant because polycythemia and thrombocythemia are contraindications to alprostadil. 1

Step 4: In-office or virtual injection training. The FDA labeling for Caverject requires that the first injection be administered in a medical setting so the provider can titrate the dose and monitor for priapism. 1 For telehealth patients, some platforms partner with local South Dakota clinics for this one-time in-person step; others conduct detailed video training and instruct patients to call immediately if an erection exceeds 4 hours.

Step 5: Pharmacy dispensing. Once prescribed, the script can be sent to a retail pharmacy, a mail-order pharmacy, or a licensed 503A compounding pharmacy. See the pharmacy section below for details specific to South Dakota.

What Labs Are Required Before Starting Alprostadil?

A standard pre-treatment lab panel for alprostadil in South Dakota includes the following tests, typically ordered before or at the time of the prescribing visit.

Morning total testosterone (reference range 300 to 1000 ng/dL) identifies coexisting hypogonadism, which affects approximately 30% of men with ED according to a 2019 analysis of 3,357 men in the Massachusetts Male Aging Study follow-up cohort. 7 Complete blood count screens for polycythemia vera (contraindication) and anemia. Comprehensive metabolic panel assesses hepatic and renal function, both of which influence cardiovascular risk stratification. Fasting lipid panel and fasting glucose or HbA1c identify metabolic contributors to vasculogenic ED. Diabetes is present in roughly 35 to 50% of men seeking ED treatment, and glycemic control independently predicts response to vasoactive therapy. 8

Prostate-specific antigen (PSA) is not required before alprostadil but is commonly co-ordered in men over 50 for routine screening under USPSTF guidelines. 9 Blood pressure measurement at or before the first visit is mandatory because uncontrolled hypertension above 170/110 mmHg should be stabilized before initiating vasoactive intracavernosal therapy. 3

Pharmacies in South Dakota That Dispense Alprostadil

Alprostadil is available through three dispensing channels in South Dakota: retail brand-name pharmacies, mail-order pharmacies, and 503A compounding pharmacies.

Retail pharmacies. Caverject Impulse (Pfizer) and MUSE (Meda Pharmaceuticals) are FDA-approved branded products. Major chains including Walgreens, CVS, and Sanford Health pharmacies in Sioux Falls and Rapid City stock or can order these products within 24 to 48 hours. Without insurance, Caverject 10 mcg (6-injection kit) lists at approximately $450, $700 at retail; GoodRx coupons may reduce this cost at participating South Dakota locations.

Mail-order pharmacies. Most large pharmacy benefit managers (Express Scripts, CVS Caremark, OptumRx) can ship alprostadil to South Dakota addresses. Confirm cold-chain shipping requirements with your insurer, as Caverject must be refrigerated after reconstitution.

503A compounding pharmacies. South Dakota law permits licensed 503A compounding pharmacies to prepare patient-specific alprostadil formulations based on a valid prescription. 10 A 503A pharmacy compounds for individual patients, not in bulk, so each order requires a prescription with the patient's name. Compounded alprostadil is typically formulated at concentrations not commercially available (e.g., 20 mcg/mL or 40 mcg/mL in a bacteriostatic saline base) to allow flexible dose titration. Compounded versions are not FDA-approved, but they are legal when prepared by an accredited South Dakota or out-of-state 503A pharmacy shipping into South Dakota. 10

Patients should verify that any compounding pharmacy they use holds current accreditation from the Pharmacy Compounding Accreditation Board (PCAB) or equivalent, and that the pharmacy is licensed by the South Dakota Board of Pharmacy. 11

Dosing: Caverject vs. MUSE

The two FDA-approved delivery systems differ substantially in both mechanism of local delivery and tolerability profile.

Caverject (intracavernosal injection). The starting dose is 2.5 mcg for vasculogenic ED or 1.25 mcg for neurogenic ED. The dose is titrated upward in the clinic by 5 to 10 mcg increments until the patient achieves a firm erection lasting 30 to 60 minutes. The effective home-use dose ranges from 5 mcg to 40 mcg per injection. 1 The Linet et al. trial found a mean effective dose of approximately 22 mcg in men with mixed ED etiology. 2

MUSE (urethral suppository). Available in 125 mcg, 250 mcg, 500 mcg, and 1000 mcg pellets inserted intraurethrally. A key multicenter trial (N=1,511) showed 43% of MUSE-treated men achieved erections sufficient for intercourse at home vs. 9% of placebo-treated men (P<0.001). 12 MUSE has lower efficacy than intracavernosal injection but is preferred by patients with needle aversion or anticoagulant therapy that raises bleeding risk.

Both formulations are used on-demand, with a maximum frequency of once per 24 hours and no more than three times per week per FDA labeling. 1

Insurance and Prior Authorization in South Dakota

South Dakota Medicaid does not cover alprostadil for erectile dysfunction. Commercial insurers vary significantly, and prior authorization (PA) is common.

A typical PA packet for alprostadil in South Dakota includes documentation of at least two failed trials of oral PDE5 inhibitors (with drug names, doses, and duration), laboratory evidence of organic ED etiology (vasculogenic, neurogenic, or post-prostatectomy), and physician attestation that the patient is an appropriate candidate. 3 Insurers typically require ICD-10-CM code N52.01 (erectile dysfunction due to arterial insufficiency), N52.1 (erectile dysfunction due to diseases classified elsewhere), or Z87.39 (personal history of other endocrine, nutritional, and metabolic diseases) to accompany the PA request.

Average PA processing time through South Dakota commercial carriers (Wellmark BlueCross BlueShield, Sanford Health Plan, Avera Health Plans) runs 3 to 14 business days. Urgent PA can be requested if the prescriber documents a clinical urgency, which shortens the window to 72 hours under South Dakota Division of Insurance rules. 13

The HealthRX Clinical Team developed the following decision framework for South Dakota patients pursuing alprostadil coverage:

1. Document two oral PDE5 inhibitor failures (sildenafil 100 mg x 6 attempts AND tadalafil 20 mg x 6 attempts) before the PA submission.
2. Submit testosterone, CBC, and metabolic labs with the PA to preempt insurer requests.
3. Include the urology or primary care visit note referencing the AUA 2018 ED guideline recommendation for second-line therapy.
4. If PA is denied, request a peer-to-peer review between your prescriber and the insurer's medical director within 10 business days of denial.

Who Can Prescribe Alprostadil in South Dakota?

Any licensed prescriber in South Dakota can write for alprostadil. This includes MDs, DOs, nurse practitioners (APRNs), and physician assistants (PAs). South Dakota grants APRNs independent prescribing authority for non-controlled substances, meaning no physician co-signature is required for NP-issued alprostadil prescriptions. 4

Urologists, men's health specialists, and primary care providers all routinely prescribe alprostadil. The key legal requirement is an established provider-patient relationship, which telehealth visits satisfy under South Dakota law when a synchronous audio-video encounter occurs. 4

Out-of-state telehealth clinicians must hold either a South Dakota medical license or an active IMLC compact privilege before prescribing to a South Dakota patient. 5 Patients should confirm their telehealth provider's licensure status through the South Dakota Board of Medical and Osteopathic Examiners public license lookup before the visit. 14

Safety, Side Effects, and Monitoring

Alprostadil carries a well-characterized safety profile established across more than two decades of post-marketing use. The most serious adverse event is priapism, defined as an erection persisting beyond 4 hours. The Linet et al. trial reported a priapism rate of 1.3% during home use. 2 Patients must be instructed to seek emergency care immediately for any erection lasting more than 4 hours, as corporal fibrosis and permanent ED can result from prolonged ischemic priapism. 15

Other common adverse effects include penile pain at the injection site (reported by approximately 30% of Caverject users in the Linet trial), penile fibrosis or nodules with long-term use (3 to 8%), hypotension (3%), and urethral burning with MUSE (12% in the key MUSE trial). 2 12

Follow-up visits at 3 months and 12 months are standard practice to assess penile tissue changes, confirm dose adequacy, and screen for plaque formation consistent with Peyronie's disease, which may develop in a subset of long-term injection users. 3 Patients on anticoagulants (warfarin, apixaban, rivaroxaban) should use the smallest effective intracavernosal dose and apply firm pressure at the injection site for at least 5 minutes after each injection to minimize hematoma formation. 16

Transferring an Existing Alprostadil Prescription to South Dakota

Patients relocating to South Dakota from another state can transfer an existing alprostadil prescription to a South Dakota pharmacy if the prescriber holds or obtains South Dakota licensure and the prescription has refills remaining. Retail pharmacy chains (Walgreens, CVS) can transfer prescriptions electronically between locations. Mail-order prescriptions can be redirected to a South Dakota address with no change in prescriber needed.

If your out-of-state prescriber is not licensed in South Dakota and does not hold an IMLC compact privilege, you need a new prescription from a South Dakota-authorized provider before any pharmacy in the state can dispense. 4 A telehealth follow-up visit reviewing your existing dosing history is typically sufficient to generate a new prescription without repeating the full titration sequence.

How Long Does It Take to Receive Alprostadil in South Dakota?

The total timeline from first contact to first dose depends on which pathway you use.

For telehealth with a 503A compounding pharmacy, the typical timeline runs: same-day or next-day telehealth appointment, prescription transmitted within 24 hours of visit, compounding and shipping requiring 2 to 5 business days, resulting in a total of 3 to 7 days for most South Dakota zip codes.

For retail brand-name prescriptions at a local pharmacy, the timeline is faster. Caverject or MUSE can be in hand within 24 to 48 hours of the prescribing visit if the pharmacy has stock on hand, which major Sioux Falls and Rapid City locations typically do. Remote rural South Dakota locations may require a 2 to 3 day special order.

Prior authorization adds 3 to 14 business days to any pathway when commercial insurance is involved. Requesting samples from the prescriber for the first titration visit can bridge this gap in some cases. 3

A 2021 survey of 412 men with ED receiving intracavernosal therapy found that treatment delays exceeding 14 days significantly reduced patient satisfaction scores on the Sexual Encounter Profile (SEP-2), underscoring the clinical value of minimizing access gaps. 17